Clinicopathological features | n | KDM5B | ||
---|---|---|---|---|
High expression (≥Median) | Low expression (<Median) | P-value | ||
Gender | Â | Â | Â | Â |
 Male | 65 | 34 | 31 | 0.6753 |
 Female | 35 | 16 | 19 |  |
Age (years) | Â | Â | Â | Â |
  ≥ 50 | 60 | 32 | 28 | 0.5406 |
  < 50 | 40 | 18 | 22 |  |
Tumor size (cm) | Â | Â | Â | Â |
  ≥ 5 | 55 | 36 | 19 | 0.0012** |
  < 5 | 45 | 14 | 31 |  |
Tumor number | Â | Â | Â | Â |
 Solitary | 62 | 33 | 29 | 0.5368 |
 Multiple | 38 | 17 | 21 |  |
HBsAg | Â | Â | Â | Â |
 Positive | 76 | 40 | 36 | 0.4829 |
 Negative | 24 | 10 | 14 |  |
HCV | Â | Â | Â | Â |
 Positive | 11 | 8 | 3 | 0.1997 |
 Negative | 89 | 42 | 47 |  |
Cirrhosis | Â | Â | Â | Â |
 Positive | 82 | 43 | 39 | 0.4356 |
 Negative | 18 | 7 | 11 |  |
ALT (U/L) | Â | Â | Â | Â |
  ≥ 45 | 46 | 26 | 20 | 0.3158 |
  < 45 | 54 | 24 | 30 |  |
AFP (ng/ml) | Â | Â | Â | Â |
  ≥ 20 | 57 | 31 | 26 | 0.4193 |
  < 20 | 43 | 19 | 24 |  |
TNM stage | Â | Â | Â | Â |
 I + II | 56 | 21 | 35 | 0.0085** |
 III + IV | 44 | 29 | 15 |  |
Edmondson grade | Â | Â | Â | Â |
 I + II | 59 | 23 | 36 | 0.0142* |
 III + IV | 41 | 27 | 14 |  |